| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 445 |
| 1 | NIVOLUMAB | 244 |
| 2 | CARBOPLATIN | 207 |
| 3 | PACLITAXEL | 170 |
| 4 | PACLITAXEL (AIBUMIN-BOUND) | 164 |
| 5 | IPILIMUMAB | 160 |
| 6 | CYCLOPHOSPHAMIDE | 84 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 84 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 84 |
| 9 | PEMETREXED DISODIUM | 34 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TREMELIMUMAB | 20 | 0.0047 |
| 1 | PEMBROLIZUMAB | 445 | 0.0043 |
| 2 | EPIRUBICIN HYDROCHLORIDE | 24 | 0.0038 |
| 3 | IPILIMUMAB | 160 | 0.0037 |
| 4 | NIVOLUMAB | 244 | 0.0025 |
| 5 | SODIUM HYALURONATE | 2 | 0.0025 |
| 6 | ENFORTUMAB VEDOTIN | 14 | 0.0019 |
| 7 | SENNOSIDES A AND B | 3 | 0.0019 |
| 8 | PACLITAXEL | 170 | 0.0017 |
| 9 | AZILSARTAN KAMEDOXOMIL | 5 | 0.0017 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 681 | 0.0067 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 180 | 0.0038 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 29 | 0.0014 |
| 3 | Microtubule Inhibitor [EPC] | 171 | 0.0011 |
| 4 | Platinum-based Drug [EPC] | 249 | 0.0009 |
| 5 | Alkylating Drug [EPC] | 84 | 0.0004 |
| 6 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 7 | Orexin Receptor Antagonist [EPC] | 4 | 0.0002 |
| 8 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 7 | 0.0002 |
| 9 | Penem Antibacterial [EPC] | 5 | 0.0001 |